Study of NTX-2001 on Alcohol Consumption in Alcohol Use Disorder
Key facts
- Who runs it
- Newleos Therapeutics, Inc.
- Where
- New Haven, United StatesSee the site
- Trial code
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 50 people, planned
- Started
- 20 Mar 2026
- Expected to end
- Mar 2027
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- NTX-2001
- Placebo
- Record updated
- 9 April 2026
Who can take part
- Age
- 21 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (15)Hide the full registry criteria
Who can take part
- Has provided written informed consent for the study and is willing to comply with all requirements of the protocol
- English speaker
- Male or female, ≥21 and ≤60 years of age
- Has a body mass index (BMI) 18 to 35 kg/m2 inclusive
- Meets DSM-5 criteria for Alcohol Use Disorder (AUD) confirmed by Mini-International Neuropsychiatric Interview (MINI)
- If participant is of childbearing potential, must commit to practicing highly effective methods of birth control during the study and at least 14 days after the last dose
Who cannot take part
- Receiving psychotropics regularly, except for a stable dose of an antidepressant for at least 2 months prior to Screening
- Current diagnosis of substance use disorder, except for tobacco use disorder or mild cannabis use disorder as defined by the Diagnostic and Statistical Manual of Mental Disorders 5th Edition (DSM-5)
- Past or current diagnosis of schizophrenia spectrum or other psychotic disorder as defined by the DSM-5
- Has moderate or severe hepatic impairment
- Has moderate or severe renal impairment
- Currently seeking alcohol treatment or have been in alcohol treatment within the past 6 months
- Reports disliking spirits (hard liquor)
- Is at risk for suicidal ideation as per C-SSRS
- Women who are pregnant or women who are currently breastfeeding unless they plan to stop breastfeeding for the duration of the study
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Alcohol use disorder
This trial is currently available in United States.
- Yale University School of Medicine, Connecticut Mental Health CenterNew Haven, United StatesContact: Yale University School of Medicine, Connecticut Mental HealthTaking people
About the trial
What the trial wants to find out
The primary goal of this Phase 1b clinical trial is to evaluate the effects of a novel TAAR1 receptor partial agonist (NTX-2001) in adults with Alcohol Use Disorder (AUD). The main questions this trial aims to answer are:
Read full original descriptionShow less
* Does NTX-2001 affect alcohol consumption in adults with AUD? * Is NTX-2001 safe and well tolerated in adults with AUD?
Researchers will compare the effects of NTX-2001 with matching placebo (look-alike capsule that contains no drug).
Participants will:
* Take NTX-2001 or matching placebo every day for 2 weeks * Visit the clinic 4 times over the course of 10 weeks
The 2 groups in the trial
- NTX-2001Treatment being tested
- PlaceboPlacebo, for comparison
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effects of NTX-2001, a Novel TAAR1 Partial Agonist, on Alcohol Consumption in Adults With Alcohol Use Disorder: A Phase 1b, Randomized, Placebo-Controlled, Proof-of-Concept Study
- Criteria questions
- Built from NCT07520292, who can take part
- Record updated
- 9 April 2026